Hubbry Logo
Ribonuclease PRibonuclease PMain
Open search
Ribonuclease P
Community hub
Ribonuclease P
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Ribonuclease P
Ribonuclease P
Ribonuclease P
View on Wikipedia
from Wikipedia
Crystal structure of a bacterial ribonuclease P holoenzyme in complex with tRNA (yellow), showing metal ions involved in catalysis (pink spheres), PDB: 3Q1R​

Ribonuclease P (EC 3.1.26.5, RNase P) is a type of ribonuclease which cleaves RNA. RNase P is unique from other RNases in that it is a ribozyme – a ribonucleic acid that acts as a catalyst in the same way that a protein-based enzyme would. Its function is to cleave off an extra, or precursor, sequence of RNA on tRNA molecules. Further, RNase P is one of two known multiple turnover ribozymes in nature (the other being the ribosome), the discovery of which earned Sidney Altman and Thomas Cech the Nobel Prize in Chemistry in 1989: in the 1970s, Altman discovered the existence of precursor tRNA with flanking sequences and was the first to characterize RNase P and its activity in processing of the 5' leader sequence of precursor tRNA.[1]

Its best characterised enzyme activity is the generation of mature 5′-ends of tRNAs by cleaving the 5′-leader elements of precursor-tRNAs. Cellular RNase Ps are ribonucleoproteins. The RNA from bacterial RNase P retains its catalytic activity in the absence of the protein subunit, i.e. it is a ribozyme. Similarly, archaeal RNase P RNA has been shown to be weakly catalytically active in the absence of its respective protein cofactors.[2] Isolated eukaryotic RNase P RNA has not been shown to retain its catalytic function, but is still essential for the catalytic activity of the holoenzyme. Although the archaeal and eukaryotic holoenzymes have a much greater protein content than the bacterial ones, the RNA cores from all three lineages are homologous—the helices corresponding to P1, P2, P3, P4, and P10/11 are common to all cellular RNase P RNAs. Yet there is considerable sequence variation, particularly among the eukaryotic RNAs.

In Bacteria

[edit]

Bacterial RNase P has two components: an RNA chain, called M1 RNA, and a polypeptide chain, or protein, called C5 protein.[3][4] In vivo, both components are necessary for the ribozyme to function properly, but in vitro, the M1 RNA can act alone as a catalyst.[1] The primary role of the C5 protein is to enhance the substrate binding affinity and the catalytic rate of the M1 RNA enzyme probably by increasing the metal ion affinity in the active site. The crystal structure of a bacterial RNase P holoenzyme with tRNA has been recently resolved, showing how the large, coaxially stacked helical domains of the RNase P RNA engage in shape selective recognition of the pre-tRNA target. This crystal structure confirms earlier models of substrate recognition and catalysis, identifies the location of the active site, and shows how the protein component increases RNase P functionality.[5][6]

Bacterial RNase P class A and B

[edit]

Ribonuclease P (RNase P) is a ubiquitous endoribonuclease, found in archaea, bacteria and eukarya as well as chloroplasts and mitochondria. Its best characterised activity is the generation of mature 5'-ends of tRNAs by cleaving the 5'-leader elements of precursor-tRNAs. Cellular RNase Ps are ribonucleoproteins (RNP). RNA from bacterial RNase Ps retains its catalytic activity in the absence of the protein subunit, i.e. it is a ribozyme. Isolated eukaryotic and archaeal RNase P RNA has not been shown to retain its catalytic function, but is still essential for the catalytic activity of the holoenzyme. Although the archaeal and eukaryotic holoenzymes have a much greater protein content than the eubacterial ones, the RNA cores from all the three lineages are homologous—helices corresponding to P1, P2, P3, P4, and P10/11 are common to all cellular RNase P RNAs. Yet, there is considerable sequence variation, particularly among the eukaryotic RNAs.

Bacterial RNase P class A
Predicted secondary structure and sequence conservation of RNaseP_bact_a
Identifiers
SymbolRNaseP_bact_a
RfamRF00010
Other data
RNA typeGene; ribozyme
DomainBacteria
GOGO:0008033 GO:0004526 GO:0030680
SOSO:0000386
PDB structuresPDBe
Bacterial RNase P class B
Predicted secondary structure and sequence conservation of RNaseP_bact_b
Identifiers
SymbolRNaseP_bact_b
RfamRF00011
Other data
RNA typeGene; ribozyme
DomainBacteria
GOGO:0008033 GO:0004526 GO:0030680
SOSO:0000386
PDB structuresPDBe

In Archaea

[edit]

In archaea, RNase P ribonucleoproteins consist of 4–5 protein subunits that are associated with RNA. As revealed by in vitro reconstitution experiments these protein subunits are individually dispensable for tRNA processing that is essentially mediated by the RNA component.[7][8][9] The structures of protein subunits of archaeal RNase P have been resolved by x-ray crystallography and NMR, thus revealing new protein domains and folding fundamental for function.

Using comparative genomics and improved computational methods, a radically minimized form of the RNase P RNA, dubbed "Type T", has been found in all complete genomes in the crenarchaeal phylogenetic family Thermoproteaceae, including species in the genera Pyrobaculum, Caldivirga and Vulcanisaeta.[10] All retain a conventional catalytic domain, but lack a recognizable specificity domain. 5′ tRNA processing activity of the RNA alone was experimentally confirmed. The Pyrobaculum and Caldivirga RNase P RNAs are the smallest naturally occurring form yet discovered to function as trans-acting ribozymes.[10] Loss of the specificity domain in these RNAs suggests potential altered substrate specificity.

It has recently been argued that the archaebacterium Nanoarchaeum equitans does not possess RNase P. Computational and experimental studies failed to find evidence for its existence. In this organism the tRNA promoter is close to the tRNA gene and it is thought that transcription starts at the first base of the tRNA thus removing the requirement for RNase P.[11]

Archaeal RNase P
Predicted secondary structure and sequence conservation of Archaeal RNase P
Identifiers
SymbolRNaseP_arch
RfamRF00373
Other data
RNA typeGene; ribozyme
DomainArchaea
GOGO:0008033 GO:0004526 GO:0030680
SOSO:0000386
PDB structuresPDBe
Archaeal RNase P class T
Identifiers
SymbolRNaseP-T
RfamRF02357
Other data
RNA typeGene; ribozyme
DomainArchaea
GOGO:0008033 GO:0004526 GO:0030680
SOSO:0000386
PDB structuresPDBe

In eukaryotes

[edit]

Nuclear RNase P

[edit]
Nuclear RNase P
Predicted secondary structure and sequence conservation of RNaseP_nuc
Identifiers
SymbolRNaseP_nuc
RfamRF00009
Other data
RNA typeGene; ribozyme
Domain(s)Eukaryota; Bacteria; Archaea
GOGO:0008033 GO:0004526 GO:0030677
SOSO:0000386
PDB structuresPDBe

In eukaryotes, such as humans and yeast,[12] most RNase P consists of an RNA chain that is structurally similar to that found in bacteria [13] as well as nine to ten associated proteins (as opposed to the single bacterial RNase P protein, C5).[14][15] Five of these protein subunits exhibit homology to archaeal counterparts.

Recent (2007) findings also reveal that eukaryotic RNase P has a new function:[14] It has been shown that human nuclear RNase P is required for the normal and efficient transcription of various small noncoding RNAs, such as tRNA, 5S rRNA, SRP RNA and U6 snRNA genes,[16] which are transcribed by RNA polymerase III, one of three major nuclear RNA polymerases in human cells.

RNase P from eukaryotes was only recently (2007) demonstrated to be a ribozyme.[17] Accordingly, the numerous protein subunits of eukaryotic RNase P have a minor contribution to tRNA processing per se,[18] while they seem to be essential for the function of RNase P and RNase MRP in other biological settings, such as gene transcription and the cell cycle.[16][19]

Subunits and functions of human RNase P [14]
Subunit Function/interaction (in tRNA processing)
RPP14 RNA binding
RPP20 ATPase, helicase/Hsp27, SMN, Rpp25
RPP21 RNA binding, activityg/Rpp29
RPP25 RNA binding/Rpp20
RPP29 tRNA binding, activity/Rpp21
RPP30 RNA binding, activity/Pop5
RPP38 RNA binding, activity
RPP40
hPop1
hPop5 RNA binding, activity/Rpp30
H1 RNA Activity/Rpp21, Rpp29, Rpp30, Rpp38

RNase MRP

[edit]

Protein subunits of RNase P are shared with RNase MRP,[15][20][21] an evolutionarily related catalytic ribonucleoprotein involved in processing of ribosomal RNA in the nucleolus and[22] DNA replication in the mitochondrion.[23]

Organellar RNase P

[edit]

Most eukaryotes have mitochondria, an organelle derived from proteobacteria, or a reduced version. Some also have chloroplasts, an organelle derived from cyanobacteria. These organelles have their own genome and machinery for transcription and translation. They make their own tRNAs, which requires maturation by RNase P.

Bacteria-derived

[edit]

As expected for the endosymbiotic theory – and similarly to other organellar genes – RNase P RNA genes (Rpm1 in yeast nomenclature or rnpB in bacterial nomenclature) have in the mitochondrial genome of the baker's yeast and most of its relatives in Saccharomycetales. These RNAs are extremely minimized ("crippled" according to Rossmanith) and do not work alone in vitro. They also show high divergence even among related yeasts. The baker's yeast version has one identified protein partner Rpm2, the only protein partner to mitochondrial RNase P RNA a known as of 2012. The identification of rnpB in the broader category of fungi remains patchy.[24]

Among Archaeplastida ("broader plants": plants, green algae, red algae), only two early-branching prasinophytes have a mtRNase P RNA gene. The secondary structure resembles α-proteobacterial RNase P RNA, but they do not work alone in vitro. It is unknown what the required protein partner is.[24] The glaucophytes, red algae, and some prasinophytes have a bacterial type A RNase P RNA in their chloroplast genomes. Other plants use the protein-only system described below.[24]

The situation among so-called protists is less clear due to the lack of data. The jakobid Reclinomonas americana is notable for having a mtRNase P RNA believed to be the closest to the version in the proto-mitochondrion, though it also does not work alone in vitro.[24] (Mixing and matching parts from this RNA with the E. coli P-RNA does produce an RNA that is active alone.)[25]

No mitochondrial mtRNase P RNA has been found among animals as of 2012. Most of them have a copy of the protein-only system identified.[24]

Eukaryotic protein-only RNase P

[edit]
Protein-only RNase P, C-terminal catalytic
Identifiers
SymbolPRORP_C
PfamPF16953
InterProIPR031595
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

The alternative to a RNA-based RNase P in animals and plants is the protein-only RNase P (PRORP). Most PRORPs consist of a C-terminal metallonuclease PIN domain and an N-terminal pentatricopeptide repeat (PPR) domain,[26] but variations exist.[27]

The PRORP was originally discovered in plants, specifically in Spinach chloroplasts.[28] The model plant Arabidopsis thaliana has three protein-only RNase P genes: PRORP1, PRORP2, PRORP3. PRORP1 goes to the mitochondria and chloroplasts while PRORP2 and PRORP3 stays in the nucleus. All can cleave tRNA in vitro. The plant version has all functionalities in one chain of protein.[29]

Human mitochondrial RNase P is a trimeric protein and does not contain RNA. It consists of TRMT10C, HSD17B10, and the catalytic PRORP.[30] Its structure has been solved. The PPR domain in human PRORP does not perform base recognition, unlike in plant single-protein PRORPs.[31] Other animals have a similar setup. Even nematodes have a divergent version of this trimeric system.[24]

The kinetoplastids also have PRORP.[24]

Prokaryotic protein-only RNase P

[edit]
RNA-free ribonuclease P / PINc domain ribonuclease
Identifiers
SymbolPIN_5
PfamPF08745
InterProIPR014856
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Some prokrayotes (bacteria and archaea) have a single-protein RNase P quite different from the eukaryotic PRORP. They are called HARP (Homologs of Aquifex RNase P). They are tiny proteins of up to 23 kDa. They only share sequence similarity with eukaryotic PRORP in one region, the metallonuclease PIN domain. Some of them form high-order oligomers.[32]

HARP does not carry out the functions of RNase P very efficiently. Many organisms that have HARP also have a typical RNase P. This hints at a different function. In 2025, it was found that HARP has a tendency to appear with the RNA ligase protein. A new theory backed by immunodepletion is that it acts with RNA ligase to mature and circularize C/D box snoRNAs.[33]

Therapies using RNase P

[edit]

RNase P is now being studied as a potential therapy for diseases such as herpes simplex virus,[34] cytomegalovirus,[34][35] influenza and other respiratory infections,[36] HIV-1[37] and cancer caused by fusion gene BCR-ABL.[34][38] External guide sequences (EGSs) are formed with complementarity to viral or oncogenic mRNA and structures that mimic the T loop and acceptor stem of tRNA.[36] These structures allow RNase P to recognize the EGS and cleave the target mRNA. EGS therapies have shown to be effective in culture and in live mice.[39]

References

[edit]

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Ribonuclease P

View on Grokipedia
from Grokipedia
Ribonuclease P (RNase P) is an ancient and essential ribonucleoprotein endoribonuclease that catalyzes the removal of the 5' leader sequence from precursor transfer RNAs (pre-tRNAs) to generate mature tRNAs, a critical step in tRNA biogenesis conserved across all domains of life. The enzyme's core catalytic component is a —an RNA subunit capable of enzymatic activity—associated with one or more protein cofactors that enhance stability, substrate binding, and efficiency, depending on the organism. First identified in the as a tRNA-processing factor in , RNase P's RNA subunit was demonstrated to possess true catalytic properties in 1983, revolutionizing the understanding of 's biochemical roles and earning its discoverer, , the 1989 (shared with ). Structurally, bacterial RNase P, the simplest form, comprises a single catalytic RNA (P RNA, typically around 350–450 ) organized into two main domains—a catalytic (C) domain responsible for cleavage and a specificity (S) domain for substrate recognition—and one protein subunit (typically around 110–130 ) that binds conserved regions of the to facilitate pre-tRNA positioning. occurs via a two-metal- mechanism involving magnesium ions, where one ion activates the 2'-OH on the pre-tRNA leader and the other stabilizes the , enabling site-specific endonucleolytic cleavage in an Mg²⁺-dependent manner. In and eukaryotes, RNase P is more complex, incorporating additional proteins (up to five in and ten in eukaryotes, including POP5, RPP30, and POP1) that expand its functional repertoire, such as nuclear localization in eukaryotes and of non-tRNA substrates like ribosomal RNAs or viral RNAs. As a relic of the hypothesis, RNase P predates the , with its core evolving early in life's history before the accretion of protein subunits that improved its performance under diverse cellular conditions. This evolutionary conservation underscores its indispensable role in translation, while variations in composition reflect adaptations to increasing cellular complexity from to eukaryotes. Beyond tRNA maturation, RNase P influences gene regulation and has been harnessed in for RNA-targeted therapies, such as external guide sequence (EGS)-mediated cleavage of pathogenic RNAs.

Overview and Discovery

Definition and Primary Function

Ribonuclease P (RNase P) is a ribonucleoprotein complex that serves as an essential endoribonuclease, catalyzing the site-specific cleavage of the 5' leader from precursor tRNAs (pre-tRNAs) to produce the mature 5' terminus of functional tRNAs. This processing step is critical for tRNA biosynthesis, enabling the tRNAs to participate in protein synthesis by ensuring their proper structural integrity and recognition by the translational machinery. RNase P is universally conserved and present in all three domains of life—, , and Eukarya—with its component functioning as the catalytic subunit, classifying it as a . The alone exhibits catalytic activity in under high monovalent and divalent cation concentrations, although protein subunits enhance efficiency and specificity in , with the number of proteins varying by organism (one in , 4–5 in , and up to 10 in eukaryotes). This nature underscores RNase P's role as a fundamental -based catalyst in cellular RNA processing. The primary substrate for RNase P is pre-tRNA, where cleavage occurs at a precise site immediately upstream of the mature 5' end, generating a product with a 5' monophosphate (at the n+1 position relative to the mature tRNA sequence) and a 3' hydroxyl terminus on the excised leader. This conserved 5' is uniform across species and essential for subsequent tRNA modifications and aminoacylation. Discovered as one of the first ribozymes, RNase P holds significant evolutionary importance, providing early evidence of RNA's capacity for catalysis independent of proteins and supporting models of an ancient where RNA enzymes dominated early cellular . Its conservation across billions of years of highlights its indispensable role in the universal process of tRNA maturation.

Historical Discovery and Significance

Ribonuclease P (RNase P) was first identified in 1971 by during studies on tRNA biosynthesis in , where he observed an endonucleolytic activity that specifically cleaved precursor tRNAs to generate mature 5' termini. This discovery built on earlier observations of tRNA precursors but pinpointed RNase P as the key enzyme responsible for their processing. In the ensuing years, through purification and characterization efforts, Altman and collaborators confirmed RNase P as a ribonucleoprotein complex essential for tRNA maturation across organisms. During the 1970s and , research by Altman and his team revealed the RNA subunit's central role, culminating in the landmark 1983 experiment demonstrating that the M1 RNA component from E. coli could catalyze precursor tRNA cleavage without any protein subunits under high-magnesium conditions. This finding, independently supported by biochemical assays showing RNA-dependent activity, established RNase P as the first naturally occurring , challenging the prevailing view that only proteins could act as biological catalysts. The implications extended to the hypothesis, suggesting ancient RNA-based catalysis in early life. For this breakthrough in demonstrating RNA's enzymatic potential—paralleled by Thomas Cech's work on self-splicing introns—Altman and Cech shared the 1989 . Structural studies in the early provided atomic-level insights into RNase P's and mechanism. In 2005, the of the full-length RNase P from stearothermophilus was resolved at 3.3 Å resolution, revealing a compact core with conserved helices that form the for substrate recognition and . Subsequent work in 2011 yielded the first of a bacterial RNase P holoenzyme in complex with tRNA, elucidating how protein subunits enhance RNA stability and efficiency . These milestones affirmed the RNA subunit's catalytic dominance while highlighting protein contributions.

General Structure and Mechanism

Ribonucleoprotein Composition

Ribonuclease P (RNase P) is a ribonucleoprotein (RNP) complex composed of a single catalytic subunit and one or more protein subunits that enhance its function without contributing directly to . The RNA component, known as RNase P RNA (RPR), forms the core of the holoenzyme and is essential for activity across all domains of life. The protein subunits, varying in number from one in to up to ten in eukaryotes, primarily assist in RNA folding, substrate binding, and overall complex stability. The conserved catalytic domain of the RPR consists of two main helical regions comprising P1 through P4, along with a structure in the P4 that facilitates substrate recognition. This core domain is universally preserved and responsible for the ribozyme's endonucleolytic activity on precursor tRNAs. The RPR typically ranges from 350 to 500 in length, with the holoenzyme mass varying from approximately 100 in simple bacterial forms to 600 in more complex eukaryotic assemblies, reflecting the increasing protein content. Key structural motifs in the RPR include the L11 binding loop, which mediates interactions with protein subunits resembling ribosomal protein L11, thereby stabilizing the structure in archaeal and eukaryotic forms. Additionally, the S-domain (specificity domain) recognizes the mature tRNA domain through base-pairing and tertiary interactions, facilitating precise positioning of the 5' leader sequence at the cleavage site. These motifs ensure efficient assembly and function of the RNP complex.

Catalytic Mechanism of tRNA Processing

Ribonuclease P (RNase P) initiates tRNA maturation by binding the precursor tRNA (pre-tRNA) substrate through specific RNA-RNA interactions that recognize the mature tRNA domain. The 3' acceptor stem of the pre-tRNA, including the CCA sequence, docks into a cleft formed by the P RNA subunit, where it base-pairs with the L15 loop in the P15 stem-loop region. This binding positions the 5' leader sequence adjacent to the , enabling precise recognition of the cleavage site one upstream of the mature 5' end. The catalytic reaction proceeds via Mg²⁺-dependent , where water acts as the to cleave the at the 5' end of the pre-tRNA. This endonucleolytic cleavage generates a mature tRNA with a 5'- terminus and a 3'-hydroxyl leader fragment, as depicted in the reaction: pre-tRNA+H2O→mature tRNA (5’-P)+leader (3’-OH)\text{pre-tRNA} + \text{H}_2\text{O} \rightarrow \text{mature tRNA (5'-P)} + \text{leader (3'-OH)} At least two Mg²⁺ ions are required, with optimal activity observed at concentrations above 20 mM, facilitating the nucleophilic attack and stabilization of the . The kinetics follow a two-metal-ion mechanism, where one Mg²⁺ ion activates the hydrolytic as a general base, while the second acts as a general acid to protonate the oxygen, stabilizing the pentacoordinate during SN2-like phosphodiester bond breakage. The P RNA positions these ions near the cleavage site through coordination with non-bridging phosphate oxygens and ribose hydroxyls, enabling general acid-base catalysis by the . , the component alone catalyzes pre-tRNA processing efficiently under high conditions (e.g., elevated Mg²⁺ or monovalent salts), demonstrating intrinsic activity. However, , the protein subunits are essential for enhancing substrate affinity, reaction rate, and specificity under physiological salt concentrations, ensuring efficient tRNA maturation in cellular environments.

RNase P in Prokaryotes

Bacterial RNase P

Bacterial ribonuclease P (RNase P) enzymes are ribonucleoproteins classified into two primary structural classes, A and B, based on the architecture of their RNA subunit. Class A RNase P, predominant in Gram-negative bacteria and high-GC Gram-positive bacteria such as Escherichia coli, comprises a single catalytic RNA molecule (P RNA, encoded by rnpB) of approximately 350–400 nucleotides and one essential protein subunit (P protein, encoded by rnpA, ~120 amino acids or ~14 kDa). The RNA alone exhibits ribozyme activity in vitro, but the protein enhances catalytic efficiency, substrate binding, and stability in vivo. In contrast, Class B RNase P, found mainly in low-GC Gram-positive bacteria like Bacillus subtilis, features a P RNA with an expanded specificity domain containing additional helical elements (e.g., helix L15.1), resulting in a slightly larger RNA (~420 nucleotides). The B. subtilis holoenzyme assembles as a dimer, incorporating two P RNA and two P protein subunits, which supports cooperative function while maintaining the core RNA-driven catalysis. The structural organization of bacterial RNase P centers on the P RNA, which folds into a conserved catalytic domain (C-domain) and a substrate-specificity domain (S-domain). The C-domain includes the , a key that positions two Mg²⁺ ions essential for the enzyme's endonucleolytic cleavage mechanism, while the S-domain recognizes the T-loop and acceptor stem of precursor tRNA substrates. High-resolution structures, such as the 3.2 Å crystal structure of the Thermotoga maritima (Class A) holoenzyme bound to tRNA^Phe^ (PDB: 3Q1R), illustrate how the interacts with the RNA's P15-P16-P17 region via electrostatic contacts, rigidifying the S-domain and expanding the cleft for efficient substrate accommodation. Cryo-EM studies of E. coli RNase P (PDB: 7UO1) further confirm these RNA-protein interfaces, highlighting conserved interactions that stabilize the holoenzyme under physiological conditions. Functionally, bacterial RNase P exhibits adaptations that enable high catalytic efficiency in diverse cellular environments. The P protein significantly boosts activity at low Mg²⁺ concentrations (~1–3 mM), which are typical in bacterial , by neutralizing RNA phosphates and facilitating substrate delivery to the RNA —contrasting with the RNA subunit's requirement for higher Mg²⁺ (~10 mM) alone. In certain bacterial , such as those with polycistronic transcripts containing both tRNA and rRNA elements, RNase P contributes to rRNA precursor processing by cleaving at 5' sites analogous to tRNA maturation, ensuring coordinated alongside its primary tRNA role. Genomically, the rnpA and rnpB genes are generally transcribed independently, with rnpA co-transcribed in a conserved alongside rpmH (encoding ribosomal protein L34) to coordinate protein availability with translation demands.89038-X/fulltext)

Archaeal RNase P

Archaeal RNase P is a ribonucleoprotein composed of a single type T subunit, typically around 250–350 in length, which represents the smallest functional RNase P among the domains of , and four to five protein subunits that enhance its catalytic efficiency. The adopts a compact secondary dominated by a well-defined catalytic (C) domain, lacking the elaborate S-domain extensions characteristic of bacterial RNase P RNAs, thereby emphasizing a minimalistic adapted to archaeal . The protein components, often referred to as Pop and Rpp (RNase P protein) subunits, include Pop5, Rpp21, Rpp29, Rpp30, and Rpp38 (also known as L7Ae), with homologs such as Ph1771p for Rpp29. These proteins assemble in a hierarchical manner, forming stable subcomplexes like Pop5–Rpp30 and Rpp21–Rpp29 that bind sequentially to the RNA, stabilizing its active conformation and facilitating substrate binding. Structural analyses, including structures of archaeal RNase P protein subcomplexes determined around 2010, reveal that these proteins interact directly with conserved RNA helices in the catalytic core, such as helices P1–P4, to rigidify the and promote magnesium-dependent cleavage. The 2019 cryo-EM structure of the Methanocaldococcus jannaschii RNase P holoenzyme at 4.1 Å resolution further illustrates how the five proteins encircle the compact type T , providing extensive stabilization to the minimal C-domain while leaving the S-domain relatively protein-free. A notable exception occurs in the parasitic archaeon Nanoarchaeum equitans, which lacks both the RNA and protein components of RNase P due to extreme reduction; instead, its tRNAs are transcribed without 5' leaders, obviating the need for , or it relies on its host Ignicoccus hospitalis for maturation. In thermophilic , such as Methanothermobacter thermoautotrophicus, sequence variations in the RNase P , including increased G-C content in key helices and specific substitutions, confer enhanced thermal stability, enabling activity at temperatures exceeding 60°C without compromising fidelity. Functionally, archaeal RNase P is indispensable for tRNA 5' end maturation by site-specifically cleaving precursor tRNAs, ensuring proper tRNA biogenesis in the archaeal cell. The type T RNA and associated proteins have co-evolved with archaeal tRNA genes, particularly in the recognition of the TψC-loop and structure of tRNA substrates, to optimize processing efficiency across diverse archaeal lineages.

RNase P in Eukaryotes

Nuclear RNase P

Nuclear RNase P in eukaryotic cells is a complex ribonucleoprotein responsible for the maturation of precursor tRNAs transcribed in the nucleus. It consists of a single catalytic subunit classified as type A, which varies in length from approximately 340 in humans (H1 RNA) to around 370 in species like , and 10 protein subunits that enhance stability, substrate recognition, and under physiological conditions. In humans, the protein components include members of the ribonuclease P protein (RPP) family—such as RPP14, RPP20, RPP21, RPP25, RPP29, RPP30, RPP38, and RPP40—along with POP1 and POP5, several of which are shared with the related RNase MRP complex to facilitate coordinated RNA processing functions. These proteins form an interlocked scaffold that clamps around the RNA, contributing over 70% of the holoenzyme's mass and enhancing the RNA-based observed in prokaryotes, with proteins playing a greater supportive role. Recent cryo-EM structures, achieved in the late 2010s for and nuclear RNase P, have illuminated its asymmetric architecture at near-atomic resolution (3.5-3.9 ). The features a conserved catalytic (C) domain responsible for cleavage and an extended specificity (S) domain with additional helices that enable precise recognition of the pre-tRNA leader sequence. The proteins organize into two lobes that sandwich the , with POP1 and RPP subunits bridging the C and S domains to create a pre-tRNA binding cleft, revealing how eukaryotic complexity allows for efficient processing in the crowded nuclear environment while accommodating diverse substrates. Beyond its canonical role in 5' end maturation of nuclear-encoded pre-tRNAs—via a two-metal-ion mechanism that positions the scissile for —nuclear RNase P also cleaves select small non-coding s, including 7SL RNA, the core component of the (SRP) involved in protein targeting to the . This expanded substrate repertoire underscores its involvement in broader RNA and biogenesis pathways within the nucleus. The assembly and activity of nuclear RNase P are regulated in a cell cycle-dependent manner, with subunit recruitment to and association with promoters peaking during proliferation phases to support heightened tRNA demand. Dysregulation of RNase P, often through mutations in its subunits, has been implicated in various due to shared components with RNase MRP, which amplify effects in related developmental disorders.

RNase MRP

RNase MRP is an essential eukaryotic ribonucleoprotein endoribonuclease that evolved as a paralog of nuclear RNase P through of the RNA component in early eukaryotes, enabling specialized functions distinct from tRNA processing. This complex shares a conserved catalytic RNA core with RNase P but diverges in substrate recognition and regulatory roles, reflecting its adaptation for ribosomal RNA maturation and control. The composition of RNase MRP centers on the MRP RNA (RMRP), a ~270-nucleotide catalytic RNA, assembled with multiple protein subunits that overlap significantly with those of nuclear RNase P. In metazoans, it incorporates nine shared proteins—POP1, POP5, RPP14, RPP20, RPP25, RPP29, RPP30, RPP38, and RPP40—which stabilize the RNA and contribute to , along with two MRP-specific subunits, NEPRO (also known as RMRP-P3) and C18ORF21 (RMRPP1), that confer substrate specificity. The structural architecture, resolved by cryo-EM at 3.0 Å resolution in , reveals a 450 kDa holoenzyme featuring a single-layered MRP RNA with coaxially stacked helices, including a conserved C-domain for (analogous to RNase P) and a divergent S-domain. A hallmark feature is the unique P3 domain in MRP RNA, which binds ribosomal RNA substrates via interactions with accessory proteins like Pop6 and Pop7, enabling precise endonucleolytic cleavage; this domain is absent or modified in RNase P, underscoring evolutionary divergence. Like nuclear RNase P, RNase MRP employs a shared catalytic core involving CR-IV and CR-Va motifs for hydrolysis, but auxiliary elements such as the P5/P8 stack and a 5'-GAA GA-3' tetraloop in the S-domain adapt it for non-tRNA targets. The primary function of RNase MRP is the site-specific cleavage of pre-rRNA at the A3 site in the 1 (ITS1), separating the 27SA pre-rRNA to facilitate maturation of 5.8S rRNA and assembly of the large ribosomal subunit, a process critical for 60S . This activity occurs in the and is conserved across eukaryotes, with depletion leading to accumulation of unprocessed pre-rRNA and impaired . Beyond rRNA processing, RNase MRP regulates mitotic progression by cleaving target mRNAs, such as CLB2 in , which encodes a cyclin B-like protein, thereby controlling G2/M transition and preventing mitotic errors. It also contributes to the cellular response to DNA replication stress, integrating into chromatin-associated pathways to maintain genome integrity during S-phase challenges, potentially through processing of replication-related transcripts or coordination with DNA damage checkpoints. These multifaceted roles highlight RNase MRP's integration into broader ribonucleoprotein networks for cellular . Dysfunction of RNase MRP is linked to several human diseases, primarily through mutations disrupting complex assembly or activity. Mutations in the RMRP gene, such as the common 70A>G variant, cause cartilage-hair hypoplasia (CHH), a pleiotropic autosomal recessive disorder characterized by short-limbed , sparse hair, , and variable , classified as a ribosomopathy due to defective pre-rRNA processing and reduced abundance. Similar RMRP mutations underlie related skeletal dysplasias, including metaphyseal, anauxetic, and kyphomelic dysplasia, as well as , a with autoimmune features. Mutations in the POP1 gene, encoding a core shared subunit, result in severe skeletal dysplasias like anauxetic dysplasia, with phenotypes ranging from mild to lethal, often due to impaired complex stability and rRNA cleavage efficiency. RNase MRP's involvement in extends to altered expression of interferon-stimulated genes and defective T-cell activation in CHH patients, linking ribonucleoprotein defects to immune dysregulation.

Organellar and Protein-Only RNase P

Bacteria-Derived Organellar Forms

Mitochondria and , derived from ancient bacterial endosymbionts, frequently retain ribonucleoprotein (RNP) forms of RNase P that resemble the bacterial enzyme, enabling the processing of organelle-encoded precursor tRNAs essential for local protein synthesis. These organellar RNase Ps process the 5′ ends of pre-tRNAs transcribed from compact, often polycistronic operons in mitochondrial and chloroplast genomes, ensuring mature tRNAs are available for of a of organelle proteins involved in energy production. Unlike nuclear eukaryotic RNase P, these forms parallel bacterial class A enzymes in their reliance on a catalytic core. The composition of bacteria-derived organellar RNase P is simplified compared to bacterial counterparts, typically featuring a single catalytic RNA subunit and one to three proteins. In mitochondria, for instance, the complex comprises the mitochondrially encoded RPM1 (~483 ) and the nuclear-encoded Rpm2 protein, a pentatricopeptide repeat (PPR)-containing subunit that enhances stability and substrate binding. Similarly, in the mitochondria of the jakobid Reclinomonas americana, a bacteria-like P associates with minimal protein components to catalyze tRNA maturation. examples include the green alga Ostreococcus tauri, where a distinct, plastid-encoded RNase P (~350 ) pairs with a nuclear-encoded bacterial-like P protein (RnpA homolog) for activity. These RNAs exhibit structural conservation with bacterial class A motifs, such as the conserved (CUGA) loop and P4 , but are adapted with shorter helices to suit the gene-dense organelle environment. Functionally, these RNP enzymes are indispensable for , as defects in tRNA disrupt the synthesis of respiratory or photosynthetic proteins. In protists like Reclinomonas americana, the mitochondrial RNase P retains a highly bacterial-like , reflecting incomplete endosymbiotic transfer, while in some fungal lineages such as Saccharomycetales, the remains mitochondrially encoded despite nuclear relocation of most genes. Variations occur across lineages; for example, in certain , chloroplast P RNAs show patchy conservation but maintain catalytic competence when reconstituted with bacterial proteins. Overall, these forms highlight the evolutionary retention of bacterial architecture in eukaryotic organelles.

Eukaryotic Protein-Only RNase P (PRORP)

Eukaryotic protein-only RNase P, known as PRORP (proteinaceous RNase P), represents an RNA-independent form of the enzyme primarily localized to organelles and, in some cases, the nucleus, where it processes the 5' leader sequence from precursor tRNAs. Unlike the canonical ribonucleoprotein (RNP) versions, PRORP consists entirely of nuclear-encoded proteins and functions as a metallo-nuclease. In plants such as , PRORP exists as three distinct isoforms—PRORP1, PRORP2, and PRORP3—each a single polypeptide targeted to specific compartments: PRORP1 and PRORP2 to mitochondria and chloroplasts, and PRORP3 to the nucleus. In humans, mitochondrial PRORP (also called MRPP3) forms a heterotrimeric complex with TRMT10C (MRPP1) and SDR5C1 (MRPP2, encoded by HSD17B10), which enhances substrate recognition and processing efficiency for organellar tRNAs. Structurally, PRORP enzymes adopt a characteristic Λ-shaped architecture, comprising an N-terminal pentatricopeptide repeat (PPR) domain with 5–7 motifs for binding, a central zinc-binding domain (ZBD) that stabilizes the protein fold via coordination of a structural Zn²⁺ , and a C-terminal NYN metallo-endonuclease domain responsible for . The PPR domain facilitates specific recognition of tRNA substrates by engaging the conserved structural "elbow" region, particularly the TψC loop (T-arm) and , mimicking aspects of RNP binding despite lacking components. The first of Arabidopsis thaliana PRORP1, resolved at 1.75 Å resolution in 2012, revealed this tripartite organization and confirmed the role of conserved and residues (e.g., Cys344, Cys347, His548, Cys565) in Zn²⁺ coordination within the ZBD. Subsequent structures of PRORP1 in complex with tRNA further illuminated how the PPR motifs interact with like G18–G19 in the D-loop and C56 in the T-loop, with the 3'-CCA end acting as an antideterminant to prevent cleavage. The catalytic mechanism of PRORP involves Zn²⁺-dependent stabilization of the , coupled with a two-metal-ion (likely Mg²⁺) pathway in the NYN domain, which cleaves the at the 5' end of pre-tRNA to generate a 5'- and 3'-hydroxyl terminus—distinct from the Mg²⁺-mediated in RNP forms. Key aspartate residues (e.g., Asp474 and Asp475 in AtPRORP1) coordinate the catalytic metals, positioning the scissile for nucleophilic attack by water. This protein-only activity is less efficient than RNP RNase P but sufficient for organellar demands, with the complex showing enhanced rates due to auxiliary subunits aiding anticodon loop recognition. Evolutionarily, PRORP exemplifies , arising once in eukaryotes through fusion of ancient NYN and PPR domains to replace RNP RNase P in organelles, likely driven by the compact organellar genomes. In Arabidopsis, null mutants of PRORP1 are embryo-lethal, while double knockouts of PRORP2 and PRORP3 cause severe seed abortion, underscoring their essentiality for tRNA maturation and viability.

Prokaryotic Protein-Only RNase P (HARP)

Prokaryotic protein-only RNase P, known as (Homologs of Aquifex RNase P), represents a rare and minimalistic variant of the that lacks any component, relying solely on protein for tRNA 5' end maturation. This form was first identified in 2017 in the hyperthermophilic bacterium Aquifex aeolicus, where it fully replaces the canonical ribonucleoprotein (RNP) RNase P due to the absence of the rnpB gene encoding the subunit. enzymes are notably small, consisting of a single polypeptide chain of approximately 23 kDa that belongs to the PIN domain-like superfamily of metallonucleases, featuring a conserved capable of hydrolyzing the at the 5' leader-pre-tRNA junction in a magnesium-dependent manner. Structurally, HARPs exhibit a compact adapted for high-temperature environments, with the PIN domain forming the catalytic core flanked by helical extensions that facilitate substrate recognition. A 2021 cryo-EM study of the HARP homolog from Halalkalicoccus tibetensis (Hhal2243) revealed a dimeric assembly, where the spike-helix domain mediates dimerization and positions the pre-tRNA for cleavage, highlighting a two-metal-ion mechanism similar to that in RNA-based RNase P but executed entirely by protein residues. More recent structural insights from 2025, including cryo-EM reconstructions of HARP dodecamers from Hydrogenobacter thermophilus in complex with multiple pre-tRNAs, demonstrate a star-shaped oligomeric state with twelve active sites, enabling simultaneous processing of several substrates and underscoring the enzyme's efficiency in minimal genomes. These structures confirm that HARP binds the mature tRNA domain via electrostatic interactions with the T-loop and , positioning the cleavage site precisely without requiring the RNA subunit for guidance. In addition to its core role in tRNA processing, recent findings link HARP to complementary maturation steps in prokaryotes lacking RNA-based RNase P. A 2025 genomic analysis identified a strong association between HARP-encoding genomes and an RNA ligase exhibiting circularization activity, suggesting that this ligase repairs 3' ends or processes aberrant transcripts generated post-cleavage, particularly in organisms like Aquifex aeolicus where pre-tRNAs have evolved shorter leaders. HARPs are distributed across select thermophilic bacteria, including genera such as Aquifex, Thermus, and Hydrogenobacter, as well as numerous archaea like Halalkalicoccus and Methanosarcina, often coexisting with RNP forms but serving as the sole RNase P in streamlined genomes. This distribution reflects an evolutionary adaptation in extreme environments, where the protein-only form provides robustness against thermal denaturation of RNA components.

Additional Functions and Evolution

Functions Beyond tRNA Processing

Beyond its canonical role in maturing the 5′ end of precursor tRNAs, RNase P exhibits diverse interactions with viral RNAs, where it can be directed to cleave mRNAs in infected cells, thereby inhibiting viral production. Additionally, the RNA component of RNase P associates with and at active tRNA and 5S rRNA genes, facilitating transcription termination and coordinating RNA processing with synthesis. Recent 2024 research highlights RNase P's involvement in mRNA surveillance, where protein subunits such as RPP20, RPP25, and POP1 process m6A-modified mRNAs to maintain transcript integrity and prevent aberrant accumulation. In processing, RNase P cleaves the 3′ end of the MALAT1 to generate a stable mascRNA fragment, a process dependent on multiple protein components including RPP14 and POP1, as identified through genome-wide screening. Regulatory functions extend to chromatin dynamics, with the Rpp29 subunit recruited to activated gene arrays to repress transcription and modulate nucleosome deposition; its depletion elevates sense RNA levels and alters accessibility. RNase P shares several protein subunits (e.g., POP1, POP5, RPP20) with RNase MRP, which processes and influences pathways through regulation and stress responses. Dysregulation of RNase P contributes to disease, particularly cancer, where overexpression of its RNA component H1 promotes tumor progression in colorectal and gastric cancers by enhancing and invasion. Studies from 2023–2025 further link RNase P subunits to transcription control, including elongation phases of III-dependent genes, via associations that fine-tune polymerase activity and .

Evolutionary Origins and Variations

Ribonuclease P (RNase P) is considered one of the most ancient enzymes, originating as a in the hypothesized , where molecules performed both catalytic and informational roles prior to the emergence of proteins. Its catalytic RNA core, responsible for cleaving the 5' leader from precursor tRNAs, is universally conserved and traces back to the (LUCA), indicating presence in all domains of life from the earliest cellular forms over 3.5 billion years ago. This conserved structure underscores RNase P's essential role in tRNA maturation across evolutionary history. In prokaryotes, the ribonucleoprotein (RNP) form represents the basal configuration, with bacterial RNase P featuring a type A RNA of approximately 350–400 and a single protein subunit comprising about 10% of the enzyme's mass. Archaeal variants show RNA size reduction to 300–350 alongside an increase to at least four proteins, accounting for roughly 45% of the mass, reflecting adaptations for greater stability in diverse environments. Type B RNAs in certain , such as low-GC Gram-positives, emerged as a derived form through , incorporating unique structural elements like P5.1 and P10.1 helices for enhanced function. Eukaryotic RNase P exhibits further through events, notably giving rise to RNase MRP, a paralogous RNP that shares a conserved catalytic core but processes distinct substrates like rRNA and transcripts. Nuclear eukaryotic forms incorporate a simplified with 9–10 proteins, comprising up to 70% of the mass, enabling to higher cellular . Protein-only variants, such as PRORP (PROteinaceous RNase P), arose as derived losses of the component in eukaryotes, evolving early in eukaryotic history as nuclear-encoded enzymes that later adapted to organelles following endosymbiotic events with -derived mitochondria and chloroplasts; phylogenomic analyses indicate multiple independent origins across lineages like Metazoa, , and . Independently, prokaryotic protein-only forms like (Homologs of Aquifex RNase P) emerged in thermophilic and , forming large homo-oligomers for thermal stability and representing a separate . In 2025, cryo-EM structural studies revealed that forms dodecameric assemblies with twelve active sites, elucidating its mechanism for site-specific tRNA cleavage. These variations highlight a trend from -dominated in prokaryotes to protein-augmented or protein-only mechanisms in eukaryotes, balancing efficiency and environmental .

Therapeutic Applications

External Guide Sequence (EGS) Technology

External guide sequence (EGS) technology harnesses the RNA cleavage activity of ribonuclease P (RNase P) to target and degrade specific messenger RNAs (mRNAs) through synthetic RNA guides. Developed in the early 1990s by Sidney Altman's laboratory, this approach builds on the enzyme's natural role in tRNA processing by using short, engineered EGS RNAs that mimic the acceptor stem of precursor tRNAs. These EGS molecules are designed to hybridize with any chosen target RNA sequence via Watson-Crick base pairing, thereby directing endogenous RNase P to cleave the target at a precise site. The mechanism parallels RNase P's processing of natural pre-tRNAs but replaces the tRNA structure with a hybrid formed between the EGS and target mRNA. The EGS contains a 3'-terminal CCA sequence and sequences complementary to the target, forming a partial tRNA-like duplex that positions the cleavage site one downstream (n+1) from the EGS-target . This complex recruits cellular RNase P, which cleaves the in the target RNA, yielding 5'-phosphorylated and 3'-hydroxyl products, analogous to the reaction: target RNA + EGS → cleaved target fragments + EGS. The process relies on the activity of RNase P's RNA subunit, enhanced by associated proteins in eukaryotic systems. In vitro studies demonstrate high cleavage efficiencies with EGS-directed RNase P, often exceeding 90% under optimized conditions, such as with or bacterial RNase P variants targeting viral or bacterial mRNAs. For instance, engineered EGS variants have achieved up to 98% reduction in target protein expression in cell-free assays by promoting near-complete mRNA cleavage. This technology offers key advantages, including the ability to target virtually any sequence through custom EGS design and the use of endogenous RNase P, eliminating the need to introduce viral vectors or foreign enzymes into cells.

Clinical and Experimental Uses

Ribonuclease P (RNase P)-based therapies utilizing external guide sequences (EGS) have shown promise in targeting viral pathogens by directing the enzyme to cleave essential viral mRNAs. Early studies demonstrated the efficacy of EGS against the herpes simplex virus (HSV) thymidine kinase (TK) gene, where engineered RNase P ribozymes reduced HSV-1 gene expression and viral growth in infected cells by over 90%, and subsequent in vivo experiments using oral delivery via Salmonella vectors inhibited viral replication in mice, reducing lesion severity in ocular infection models. Similar approaches targeted cytomegalovirus (CMV), with EGS variants cleaving the mAP and M80 mRNAs of cytomegalovirus (using a murine model for human CMV), leading to significant inhibition of viral gene expression and replication in cell cultures and reduced pathogenesis in mouse models of murine CMV infection without detectable off-target effects. For HIV-1, EGS RNAs directed RNase P to degrade tat and rev mRNAs, suppressing viral gene expression by up to 80% in human cells and inhibiting HIV-1 replication, highlighting the specificity of this strategy. In influenza virus applications, EGS-mediated targeting of the PA mRNA reduced viral production by more than 90% in cultured cells, establishing RNase P as a potent antiviral tool. In cancer therapy, RNase P ribozymes have been engineered to cleave oncogenic fusion transcripts, such as BCR-ABL in . A seminal study using M1GS ribozymes specific to BCR-ABL mRNA achieved over 95% reduction in fusion transcript levels in leukemia cells, leading to inhibited and tumor growth in nude mice xenografts, with treated tumors showing up to 80% volume reduction compared to controls. Delivery systems for EGS and associated ribozymes often employ liposomal nanoparticles for efficient cellular uptake or (AAV) vectors for sustained expression . Liposomal encapsulation has facilitated targeted delivery to infected or tumor cells, achieving high rates while minimizing extracellular degradation, as seen in antiviral models. AAV-based vectors have been used to express EGS constructs, enabling long-term RNase P-mediated cleavage in animal tissues with low . Safety profiles in these models indicate no significant off-target cleavage or adverse immune responses, supporting the feasibility of . A 2024 preclinical study on an engineered RNase P targeting the nucleocapsid mRNA of reduced viral by approximately 85% in human cells, highlighting potential for applications against SARS-CoV-2. As of November 2025, RNase P-based EGS therapies remain in , with no reported human clinical trials. However, challenges persist, including EGS RNA stability in serum, which limits to under 24 hours, and potential from repeated dosing, necessitating chemical modifications or protective carriers for clinical .

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC8595784/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC11143913/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3058908/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2803672/
  5. https://www.science.org/doi/10.1126/science.aat6678
  6. https://pubmed.ncbi.nlm.nih.gov/6197186/
  7. https://academic.oup.com/femsre/article/23/3/391/579615
  8. https://www.pnas.org/doi/10.1073/pnas.0506662102
  9. https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wrna.1835
  10. https://doi.org/10.1038/229019a0
  11. https://www.jbc.org/article/S0021-9258(20)65084-0/fulltext
  12. https://doi.org/10.1146/annurev.biochem.67.1.153
  13. https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-11-153
  14. https://www.nobelprize.org/uploads/2018/06/altman-lecture.pdf
  15. https://academic.oup.com/nar/article/40/20/10384/2414586
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC1370081/
  17. https://www.rcsb.org/structure/3Q1R
  18. https://doi.org/10.1038/s41594-022-00803-8
  19. https://www.nature.com/articles/s41467-019-10496-3
  20. https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-020-6615-z
  21. https://academic.oup.com/nar/article/38/22/7885/1043564
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC3227427/
  23. https://www.pnas.org/doi/10.1073/pnas.0508004103
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC3491384/
  25. https://www.pnas.org/doi/10.1073/pnas.1013969107
  26. https://academic.oup.com/nar/article/37/1/231/1026063
  27. https://www.pnas.org/doi/10.1073/pnas.2407579121
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC9945436/
  29. https://www.tandfonline.com/doi/full/10.1080/09168451.2017.1353404
  30. https://academic.oup.com/gpb/article/22/1/qzae016/7606778
  31. https://genesdev.cshlp.org/content/20/12/1621.full
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3759807/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC2924533/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC11870539/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC7351766/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC11838342/
  37. https://www.sciencedirect.com/science/article/abs/pii/S016895251730104X
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC8814244/
  39. https://pubmed.ncbi.nlm.nih.gov/17189938/
  40. https://academic.oup.com/mbe/article/32/12/3186/2579455
  41. https://academic.oup.com/nar/article/33/2/734/2549119
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC55890/
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC1557692/
  44. https://www.tandfonline.com/doi/full/10.4161/rna.24513
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC1370472/
  46. https://www.mdpi.com/1422-0067/15/11/20859
  47. https://genesdev.cshlp.org/content/26/10/1005.full.pdf
  48. https://doi.org/10.1101/gad.189514.112
  49. https://doi.org/10.1016/j.cell.2008.09.013
  50. https://doi.org/10.1073/pnas.1209062109
  51. https://doi.org/10.1038/ncomms2358
  52. https://doi.org/10.1038/s41594-021-00637-y
  53. https://www.pnas.org/doi/10.1073/pnas.1707862114
  54. https://elifesciences.org/articles/70160
  55. https://www.nature.com/articles/s41467-025-60002-1
  56. https://journals.asm.org/doi/full/10.1128/mbio.00449-25
  57. https://www.jbc.org/article/S0021-9258%2823%2902355-4/fulltext
  58. https://www.sciencedirect.com/science/article/pii/S0021925824001078
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC22606/
  60. https://pmc.ncbi.nlm.nih.gov/articles/PMC1482482/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC12016569/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC11463631/
  63. https://www.molbiolcell.org/doi/10.1091/mbc.e15-02-0099
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC2858038/
  65. https://www.jbc.org/article/S0021-9258(24)00105-4/fulltext
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC3858429/
  67. https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wrna.1836
  68. https://www.science.org/doi/10.1126/science.1697102
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC4600001/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC97563/
  71. https://www.pnas.org/doi/10.1073/pnas.1014975108
  72. https://www.pnas.org/doi/10.1073/pnas.0804922105
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC2705784/
  74. https://www.pnas.org/doi/10.1073/pnas.95.13.7327
  75. https://ashpublications.org/blood/article/95/3/731/138696/In-vivo-inhibition-by-a-site-specific-catalytic
  76. https://www.mdpi.com/2813-0227/5/2/12
Add your contribution
Related Hubs
User Avatar
No comments yet.